Skip to main content
. 2020 Aug 23;46(11):2287–2291. doi: 10.1111/jog.14427

Figure 1.

Figure 1

Diagnostic performance compared between CA19‐9, CA12‐5 and CEA for the discrimination of borderline or malignant and benign mucinous ovarian tumor. (Inline graphic) CA‐125 ROC area: 0.7473. (Inline graphic) CA19‐9 ROC area: 0.6793 (Inline graphic) CEA ROC area: 0.6122. (Inline graphic) Reference